Aptorum Group Limited

Short Term Long Term Short Term Comparison Long Term Comparison
  • APM
  • 1d-4.38%
  • 1w-9.25%
  • 1m10.56%
  • 1y207.84%
ATH
  • ATH Price$325.50
  • ATH Date2019-06-04
  • % since ATH-97.59%
  • % to ATH4,046.50%
ATL
  • ATL Price$1.39
  • ATL Date2024-02-08
  • % from ATL464.75%
  • Last Low Price$1.39
  • Last Low Date2024-02-08
  • % From Last Low464.75%
IPO
  • IPO Price$15.80
  • % Current ROI USD-50.32%
  • ATH Price$325.50
  • % ROI ATH 2,341,726.62%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="APM"]

Key Data [addtoany]

Current price $7.85
Sector Healthcare
Industry Biotechnology
Today's High/Low $8.48/$7.5
Volume 47,556.00
Previous Close $8.21
52 Week High/Low $11.95/$1.35
Market Cap 42,541,756.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $-0.84
Annualized Dividend $0
$7.85
[addtoany]

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers.
Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.
The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women’s health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity